- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/63 - One oxygen atom
Patent holdings for IPC class C07D 213/63
Total number of patents in this class: 134
10-year publication summary
|
7
|
8
|
8
|
3
|
9
|
5
|
4
|
6
|
2
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7930 |
5 |
| Bristol-myers Squibb Company | 4878 |
4 |
| InterMune, Inc. | 57 |
4 |
| Monsanto Technology LLC | 8284 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
3 |
| Versitech Limited | 369 |
3 |
| Vironova Thionation AB | 6 |
3 |
| Nikang Therapeutics, Inc. | 95 |
3 |
| Shanghai Runshi Medical Technology Co., Ltd | 11 |
3 |
| Ganymede Oncology, Inc. | 6 |
3 |
| Bayer Intellectual Property GmbH | 2500 |
2 |
| Dow AgroSciences LLC | 1224 |
2 |
| Battelle Memorial Institute | 2481 |
2 |
| Board of Trustees of Southern Illinois University | 101 |
2 |
| Cytokinetics, Inc. | 273 |
2 |
| Daewoong Pharmaceutical Co., Ltd. | 322 |
2 |
| FMC Corporation | 845 |
2 |
| Global Blood Therapeutics, Inc. | 183 |
2 |
| Human Biomolecular Research Institute | 24 |
2 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3369 |
2 |
| Other owners | 80 |